Another Look at the Snowflake (SNOW) Mega IPO.
We haven't looked at Snowflake (SNOW) since its amazing IPO debut. It was priced at $120 and opened for trading at $245 and closed...
Wall Street Showing Love. Hepion Pharma (HEPA), Citius Pharma (CTXR) Raise $166 Million.
Hepion (HEPA) Banked $88 Million Yesterday, Citius (CTXR) Banks $78 Million Today.
We're beginning to believe (and it may be a "brief-belief") that during...
Video: Mel Gibson Stem Cell Testimonial.
Fascinating Interview with Joe Rogen, Mel Gibson, and Dr. Neil Riordan, Early Pioneer and Stem Cell Expert.
Joe Rogan interviews Stem Cell Institute founder Neil...
Philips (PHG) Completes the Acquisition of BioTelemetry, Inc.
Combination of Philips and BioTelemetry results in a global leader in patient care management solutions for the hospital and the home
Amsterdam, the Netherlands – Royal Philips (NYSE:...
Bill Gates Warns That a Next Pandemic Could Be 10 Times Worse.
Well Alrighty Then. Just as we Were Starting to Get Comfortable Sitting on a Barstool Again..
The Microsoft co-founder explained that humanity is not prepared...
Mitesco (MITI) $0.45 to Open its First Medical Clinic.
LIVE QUOTE
By George, they did it.
Many companies public or private fall short of their ambitious plans. They either kick the can, modify plans...
Why Isn’t Big Pharma Jumping Into Psychedelics (PsyTech).
Originally in PsyTech Jan 28, 2021.
By Tessa Eskin
Big Pharma is at a crossroads. The industry’s business model relies largely on returning customers for...
Adding Citius Pharma (CTXR) $1.29 to the 2021 Biotech Portfolio.
The 2021 Biotech Six Pack, Six Stocks We Expect to Double.
We're still putting the 2021 list together now, but rather than waiting to announce...
Short Squeeze Mania.
Citius Pharma (CTXR) Locked and Loaded.
Truly Locked and Loaded. Latest $20 Million Round is Biggest News We've Seen From Citius Pharma (CTXR) Since We've...
Heads UP: ENDRA Life Science (NDRA) $1.50, up 40% Today.
Are Expectations of a 501K Approval Perking Up?
We've learned through trial and error (with the better lessons coming from error) not to keep...















